US · guidance
CMS SOM App. J, Tag W363
§483.460(j)(2) The pharmacist must report any irregularities in clients' drug regimens to the
prescribing physician and interdisciplinary team.
Guidance §483.460(j)(2)
The physician and IDT members must discuss, document and take necessary follow-up action for
any irregularities noted.
History
Rev. 135, Issued: 02-27-15, Effective: 04-27-15, Implementation: 04-27-15
Provenance
- Source
- cms.gov
- Retrieved
- 2026-07-22
- Edition
- som-2026-07-22
- Content hash
71e296fdeacf6642af2ab05dbb7cac033377c73c8184fc09951f8e7fc95ad4a6
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.